Skip to main content
. 2020 Jan 1;10(3):1296–1318. doi: 10.7150/thno.41578

Figure 18.

Figure 18

(A) Scheme of nano-MOF enabled synergistic X-RDT and immunotherapy using extremely low doses of X-rays. (B) Growth curves of CT26 and TUBO tumor-bearing mice intravenously administered with PBS, DBP-Hf, IDOi@DBP-Hf, or DBP-Hf + IDOi, with or without X-ray irradiation. Adapted with permission from Ref 7. Copyright 2018 Nature Publishing Group.